Get the Stockscreener App
0.7852
1.23%
-0.0098
Cytosorbents Corp stock is traded at $0.7852, with a volume of 29,165.
It is down -1.23% in the last 24 hours and down -20.20% over the past month.
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
See More
Previous Close:
$0.795
Open:
$0.81
24h Volume:
29,165
Relative Volume:
0.18
Market Cap:
$49.27M
Revenue:
$33.79M
Net Income/Loss:
$-18.67M
P/E Ratio:
-2.1921
EPS:
-0.3582
Net Cash Flow:
$-19.17M
1W Performance:
-4.24%
1M Performance:
-20.20%
6M Performance:
-16.47%
1Y Performance:
-21.48%
1-Day Range:
$0.77
$0.8118
1-Week Range:
$0.77
$0.86
52-Week Range:
$0.7101
$1.61
Cytosorbents Corp Stock (CTSO) Company Profile
Name
Cytosorbents Corp
Sector
Industry
Phone
973-329-8885
Address
305 COLLEGE ROAD EAST, PRINCETON, NJ
Compare CTSO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTSO
Cytosorbents Corp
|
0.785 | 49.90M | 33.79M | -18.67M | -19.17M | -0.3582 |
|
ABT
Abbott Laboratories
|
123.50 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.93 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.74 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.84 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.90 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Cytosorbents Corp Stock (CTSO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-07-23 | Initiated | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-17-20 | Initiated | Jefferies | Buy |
| Sep-01-20 | Initiated | SVB Leerink | Outperform |
| Aug-08-17 | Reiterated | Maxim Group | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| May-24-16 | Initiated | Maxim Group | Buy |
| Oct-29-15 | Upgrade | WBB Securities | Speculative Buy → Buy |
| May-12-15 | Reiterated | MLV & Co | Buy |
| Apr-01-15 | Reiterated | MLV & Co | Buy |
| Mar-05-15 | Initiated | MLV & Co | Buy |
| Feb-25-15 | Initiated | WBB Securities | Speculative Buy |
| Jan-27-15 | Reiterated | H.C. Wainwright | Buy |
View All
Cytosorbents Corp Stock (CTSO) Latest News
Will breakout in Cytosorbents Corporation lead to full recoveryFed Meeting & Weekly Momentum Picks - newser.com
What candlestick patterns are forming on Cytosorbents CorporationQuarterly Portfolio Review & Verified Technical Signals - newser.com
Cytosorbents Corporation stock volume spike explained2025 Short Interest & Community Consensus Picks - newser.com
Can machine learning forecast Cytosorbents Corporation recoveryFed Meeting & Safe Capital Investment Plans - newser.com
Is Cytosorbents Corporation stock positioned well for digital economy2025 Key Lessons & Daily Technical Forecast Reports - newser.com
Can momentum traders help lift Cytosorbents CorporationJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights - BioSpace
Cytosorbents (CTSO) to Release Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-31 00:03:46 - newser.com
Is a relief rally coming for Cytosorbents Corporation holdersJuly 2025 Momentum & Daily Profit Focused Screening - newser.com
CytoSorbents’ STAR Registry: A Closer Look at the Latest Clinical Study Update - TipRanks
CytoSorbents (NASDAQ: CTSO) sets Nov. 13 results call at 4:30 PM ET and webcast details - Stock Titan
What MACD and RSI say about Cytosorbents CorporationTrade Ideas & Fast Moving Trade Plans - newser.com
Using economic indicators to assess Cytosorbents Corporation potentialEarnings Risk Report & Community Verified Trade Alerts - newser.com
Will Cytosorbents Corporation (HQE1) stock keep high P E multiples2025 Price Action Summary & Smart Investment Allocation Tips - newser.com
Cytosorbents Corporation (CTSO) Stock Price, News, Quote & History - Yahoo! Finance Canada
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025)Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer - Morningstar
Will Cytosorbents Corporation stock recover faster than marketPortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
Published on: 2025-10-27 17:34:50 - newser.com
Cytosorbents Corp’s Latest Study Update: A Game Changer in Critical Care? - TipRanks
Published on: 2025-10-27 06:48:52 - newser.com
Why Cytosorbents Corporation (HQE1) stock remains top ratedWeekly Trading Summary & Long-Term Investment Growth Plans - newser.com
Using data tools to time your Cytosorbents Corporation exitQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Why Cytosorbents Corporation (HQE1) stock is trending on social mediaShort Setup & Accurate Technical Buy Alerts - newser.com
Leading vs lagging indicators on Cytosorbents Corporation performanceJuly 2025 Short Interest & Consistent Income Trade Recommendations - newser.com
Using flow based indicators on Cytosorbents CorporationWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Published on: 2025-10-25 13:24:21 - newser.com
Published on: 2025-10-25 08:25:22 - newser.com
Published on: 2025-10-24 04:48:34 - newser.com
Cytosorbents Corp Stock (CTSO) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):